These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22940567)

  • 1. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
    Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
    Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose.
    Ju H; Wei N; Wang Q; Wang C; Jing Z; Guo L; Liu D; Gao M; Ma B; Wang J
    Biochem Biophys Res Commun; 2011 May; 409(1):131-6. PubMed ID: 21554858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
    Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and evaluation of a competitive ELISA using a monoclonal antibody for antibody detection after goose parvovirus virus-like particles (VLPs) and vaccine immunization in goose sera.
    Wang Q; Ju H; Li Y; Jing Z; Guo L; Zhao Y; Ma B; Gao M; Zhang W; Wang J
    J Virol Methods; 2014 Dec; 209():69-75. PubMed ID: 25196452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent neutralization activity against type O foot-and-mouth disease virus elicited by a conserved type O neutralizing epitope displayed on bovine parvovirus virus-like particles.
    Chang J; Zhang Y; Yang D; Jiang Z; Wang F; Yu L
    J Gen Virol; 2019 Feb; 100(2):187-198. PubMed ID: 30547855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
    Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of human parvovirus B19 virus-like particles].
    Zou X; Dong L; Song J; Qu J; Yu X; Lu Z; Hong T
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):575-9. PubMed ID: 19637634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.
    Nan L; Liu Y; Ji P; Feng H; Chen C; Wang J; Liu D; Cui Y; Wang Y; Li Y; Zhou E; Zhang G
    Virol J; 2018 Jun; 15(1):103. PubMed ID: 29921294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles.
    Lazutka J; Simutis K; Matulis P; Petraitytė-Burneikienė R; Kučinskaitė-Kodzė I; Simanavičius M; Tamošiunas PL
    Virus Res; 2021 Jan; 292():198236. PubMed ID: 33242523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel recombinant pseudorabies virus expressing parvovirus VP2 gene: Immunogenicity and protective efficacy in swine.
    Chen Y; Guo W; Xu Z; Yan Q; Luo Y; Shi Q; Chen D; Zhu L; Wang X
    Virol J; 2011 Jun; 8():307. PubMed ID: 21679423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-scale manufacture of VP2 VLP vaccine against porcine parvovirus in Escherichia coli with high-density fermentation.
    Wang J; Liu Y; Chen Y; Wang A; Wei Q; Liu D; Zhang G
    Appl Microbiol Biotechnol; 2020 May; 104(9):3847-3857. PubMed ID: 32130468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
    Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
    Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
    Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
    Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG oligodeoxynucleotides containing GACGTT motifs enhance the immune responses elicited by a goose parvovirus vaccine in ducks.
    Lee JW; Lin YM; Yen TY; Yang WJ; Chu CY
    Vaccine; 2010 Nov; 28(50):7956-62. PubMed ID: 20933041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the glycine-rich region deleted PPV VP2 to the VLPs].
    Chen D; Guo W; Chen Y; Xu Z; Li W; Ren Y; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2011 Dec; 27(12):1729-41. PubMed ID: 22506413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and Immunogenicity of Virus-Like Particles of Feline Parvovirus from the Tiger.
    Jiao C; Zhang H; Liu W; Jin H; Liu D; Zhao J; Feng N; Zhang C; Shi J
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32188011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant ELISA using baculovirus-expressed VP2 for detection of antibodies against canine parvovirus.
    Elia G; Desario C; Pezzoni G; Camero M; Brocchi E; Decaro N; Martella V; Buonavoglia C
    J Virol Methods; 2012 Sep; 184(1-2):98-102. PubMed ID: 22664182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of an indirect ELISA for the detection of antibodies to goose parvovirus in blood serum.
    Fan JH; Zuo YZ; Yang Z; Pei LH
    Lett Appl Microbiol; 2013 Jul; 57(1):26-32. PubMed ID: 23510276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.